Rhumbline Advisers Alx Oncology Holdings Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Rhumbline Advisers holds 42,111 shares of ALXO stock, worth $77,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,111

Previous 55,220 23.74%

Holding current value

$77,063

Previous $332,000 77.11%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1.81 - $8.13 $23,727 - $106,576	-13,109 Reduced 23.74%	42,111 $76,000
Q2 2024 Aug 01, 2024	BUY	$5.84 - $17.56 $31,302 - $94,121	5,360 Added 10.75%	55,220 $332,000
Q1 2024 May 09, 2024	BUY	$10.95 - $16.79 $18,680 - $28,643	1,706 Added 3.54%	49,860 $555,000
Q4 2023 Feb 08, 2024	SELL	$4.81 - $15.38 $13,482 - $43,110	-2,803 Reduced 5.5%	48,154 $717,000
Q3 2023 Nov 09, 2023	BUY	$4.19 - $7.35 $2,543 - $4,461	607 Added 1.21%	50,957 $244,000
Q2 2023 Aug 08, 2023	BUY	$4.37 - $9.56 $50,005 - $109,395	11,443 Added 29.41%	50,350 $378,000
Q1 2023 May 11, 2023	BUY	$4.52 - $11.71 $4,203 - $10,890	930 Added 2.45%	38,907 $176,000
Q4 2022 Feb 14, 2023	BUY	$9.51 - $12.95 $51,991 - $70,797	5,467 Added 16.82%	37,977 $428,000
Q3 2022 Nov 10, 2022	BUY	$8.23 - $15.14 $28,994 - $53,338	3,523 Added 12.15%	32,510 $311,000
Q2 2022 Aug 11, 2022	BUY	$5.89 - $19.46 $62,516 - $206,548	10,614 Added 57.77%	28,987 $235,000
Q1 2022 May 12, 2022	BUY	$13.65 - $22.06 $14,387 - $23,251	1,054 Added 6.09%	18,373 $311,000
Q4 2021 Feb 10, 2022	SELL	$21.49 - $74.4 $6,489 - $22,468	-302 Reduced 1.71%	17,319 $372,000
Q3 2021 Nov 12, 2021	BUY	$52.51 - $80.91 $74,301 - $114,487	1,415 Added 8.73%	17,621 $1.3 Million
Q2 2021 Aug 05, 2021	SELL	$52.2 - $75.23 $108,001 - $155,650	-2,069 Reduced 11.32%	16,206 $886,000
Q1 2021 May 06, 2021	BUY	$62.84 - $87.68 $459,423 - $641,028	7,311 Added 66.68%	18,275 $1.35 Million
Q4 2020 Feb 10, 2021	BUY	$34.11 - $112.26 $93,017 - $306,133	2,727 Added 33.11%	10,964 $945,000
Q3 2020 Nov 12, 2020	BUY	$29.36 - $47.1 $241,838 - $387,962	8,237 New	8,237 $311,000

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $74.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Alx Oncology Holdings Inc Transaction History